Patents by Inventor Robert De Jager

Robert De Jager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD TO TREAT SMALL CELL LUNG CANCER
    Publication number: 20130203725
    Abstract: A method for treatment of small cell lung cancer (SCLC) that does not respond to first-line treatment or that progresses following cessation of first-line organoplatinum chemotherapy is provided that includes the administration of picoplatin, optionally in conjunction with a regimen of best supportive care. Multiple doses of picoplatin can be administered. The picoplatin can also treat SCLC that has metastacized to the brain.
    Type: Application
    Filed: March 4, 2011
    Publication date: August 8, 2013
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Hazel B. Breitz, Robert De Jager, Paul L. Weiden
  • USE OF PICOPLATIN TO TREAT PROSTATE CANCER
    Publication number: 20120122825
    Abstract: The invention provides a method of treatment of metastatic hormone-refractory prostate cancer involving substantially as concurrent administration of picoplatin and docetaxel. Prednisone may also be administered. Dosages and dosing regimens are provided.
    Type: Application
    Filed: May 12, 2010
    Publication date: May 17, 2012
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin MD, Hazel B. Breitz MD, Paul L. Weiden MD, Robert De Jager
  • COMBINATION THERAPY FOR OVARIAN CANCER
    Publication number: 20100260832
    Abstract: The present invention provides a method to treat ovarian cancer by the administration of effective amounts of picoplatin and doxorubicin.
    Type: Application
    Filed: May 17, 2010
    Publication date: October 14, 2010
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Michael S. Perry, Hazel B. Breitz, Cheni Kwok, Robert De Jager